← USPTO Patent Grants

Production of antibodies by modification of an autonomous heavy chain variable domain by gene conversion

Grant US12588664B2 Kind: B2 Mar 31, 2026

Assignee

CRYSTAL BIOSCIENCE INC.

Inventors

William Don Harriman, Philip A. Leighton

Abstract

This disclosure provides, among other things, a transgenic animal that uses gene conversion for antibody diversification, comprising B cells in which the endogenous immunoglobulin heavy chain locus comprises: (a) a functional immunoglobulin heavy chain gene comprising a nucleic acid encoding an autonomous heavy chain (AHC) variable domain; and (b) a plurality of pseudogenes that are operably linked to said functional immunoglobulin heavy chain gene and that donate, by gene conversion, nucleotide sequence to the nucleic acid encoding the AHC variable domain of (a), wherein the pseudogenes are upstream or downstream of the functional immunoglobulin heavy chain gene.

CPC Classifications

A01K 67/0275 A01K 2207/15 A01K 2227/30 A01K 2267/01 C07K 16/18 C07K 2317/22 C12N 15/8509

Filing Date

2019-06-05

Application No.

15734533

Claims

14